^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Cyclomics

    i
    Other names: Cyclomics
    Evidence

    News

    over1year
    Cyclomics announces that discussions with Renovaro/GEDiCube regarding a possible acquisition have stopped and that it remains an independent company ()
    "On February 13th this year (2024), Cyclomics announced that it had entered in a binding LOI with Renovaro/GEDiCube regarding the acquisition of Cyclomics by GEDiCube/Renovaro. Herewith, Cyclomics would like to state that discussions with Renovaro/GEDiCube have stopped earlier this year and that an acquisition will not take place. Cyclomics remains operating as a fully independent company and there is no change in shareholders nor control of the company."
    M&A
    2years
    Cutting edge AI company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire)
    "GEDi Cube Intl Ltd...and a wholly owned subsidiary of Renovaro Inc...announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics...Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement...Upon closing, the combined companies will aim to accelerate entry into the cancer monitoring market and gain access to integrating whole genome data into GEDiCube’s AI/Machine Learning platform."
    M&A